Welcome to The Sick Times🕊️ We're an independent news site founded by journalists @betsyladyzhets and @mileswgriffis. We report on the #LongCOVID crisis, COVID-19, and infection-associated illnesses. Support our coverage: https://t.co/aFbUhCoTDF

This week's #LongCOVID research updates: https://t.co/lQN5HWrGwk

Twice impeached. Twice acquitted. Twice elected. Donald Trump redefined American politics. But was he a threat to the republic—or its greatest defender? Find out in this short video.

Recent studies add evidence to a prior phase 3 trial, suggesting that taking Metformin during acute COVID-19 reduces the risk of risk of #LongCOVID. https://t.co/RUrOXQY8Ol

We’ve now passed one month into the U.S. government shutdown—and one month without COVID-19 or other infectious disease data updates from the CDC. COVID-19 levels seem to be in a lull between waves in much of the country, but the situation is uncertain. https://t.co/rf712pQUEh

As the federal shutdown continues, states have been forced to fall back on their own resources to spot disease outbreaks — just as respiratory illness season begins. Read more from Tim Henderson Stateline republished by The Sick Times: https://t.co/vxUEgBYNzO

"#Chronicallyill people do not have the luxury to turn away from our internal, unnameable sensations — we are always at odds with that weighty linguistic gap — and sometimes it feels worse than illness itself." https://t.co/OTH5DtZrDo via @thesicktimes #ChronicIllness

Last week, Atlanta Hawks star Kristaps Porziņģis shared his diagnosis of postural orthostatic tachycardia syndrome (POTS). https://t.co/7IlWdEeJnw

MAYFIELD HIGH SCHOOLConstitutional Violations Case October 21st, 2025 Maras vs. Mayfield High School This case is not just about one student or one school — it’s about restoring the most fundamental truth in our nation: parents have the right to defend their children’s

💊 A clinical trial for Colchicine did not find the drug effective for LC 🇮🇳 PLRC white paper: LC disproportionately affects India’s productive-age population 🧐 Researchers critiqued controversial 2024 study on ME #LongCOVID research updates: https://t.co/SfUBT1pBxf

It's been a month since RFK Jr. convened a Long COVID roundtable with leading researchers and government officials. Preliminary meetings are occurring amid the government shutdown, while some advocates call for his removal. Read more from @betsyladyzhets: https://t.co/qIA1l9YqJm

It's been a month since RFK Jr. convened top experts and officials for a Long COVID roundtable event. Not much seems to have happened at federal agencies since then. And some advocates are calling for RFK Jr.'s removal. More from me in @thesicktimes:

The U.S. is still largely without COVID-19 and other infectious disease data as the government shutdown continues. Limited COVID-19 data that we do have suggest that disease levels are still on the decline, as of mid-October. https://t.co/V4tLP5SdNH

Last chance to enter! ✨

Nicotine patches help relieve symptoms in some people with #LongCOVID. Can the science behind it lead to future therapies? https://t.co/iLR2i5j45x

Even as COVID-19 spreads at high rates, some businesses are trying to force workers to unmask. We spoke with 5 workers affected by anti-mask attitudes in their workplaces, as well as organizers and a disability law expert, about how to push back. https://t.co/Id2ak4B1rT

🔬 Large study found SARS-CoV-2 infection associated with elevated risks of HPV-related cancer 🩸 Small study found a potential blood test for ME 🧸 Researchers developed device that may be able to measure microclots in children #LongCOVID research https://t.co/T4XpvGGdI7

National COVID-19 trends data are largely unavailable this week from the CDC. The COVID-19 data that we do have, from independent wastewater surveillance & state public health departments, indicate disease levels continue to decline across most of the U.S. https://t.co/fHJu8JMy38

A group of 53 people with #LongCOVID joined a clinical trial for Vyvgart. For many of them, the treatment changed everything. Without warning, Argenx canceled the trial. Most of them have now relapsed. They're calling on the NIH and HHS to study the drug: https://t.co/sDxvSgkAR8

Risk of LC doubled in children following SARS-C0V-2 reinfection Researchers may have found a biomarker & treatment target for cognitive dysfunction in LC Clinical trial recruiting to test the GLP-1 agonist drug for LC #LongCOVID research updates: https://t.co/ac8kOy9Wmd

Getting diagnosed with hypermobility can help some people with Long COVID. Upcoming guidelines may make it easier.

We’ve hit 10K newsletter subscribers, so we’re giving away five The Sick Times swag packs, including pins, stickers, a patch, and our famous dad hat! Sign up for our newsletter, or forward a recent newsletter to a friend, then comment “10K GIVEAWAY." https://t.co/btge68jdLj

🩸Thrombotic events doubled since 2020, reinfections increase risk of Long COVID 👃 Olfactory dysfunction occurred after SARS-CoV-2 infection 🧘‍♂️ A behavioral trial is assessing a vague “mindfulness intervention” for LC This week's #LongCOVID research: https://t.co/vwNkG3SNEY